{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:13:02Z","timestamp":1768263182563,"version":"3.49.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[1998,12,1]],"date-time":"1998-12-01T00:00:00Z","timestamp":912470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"vor","delay-in-days":7696,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1998,12]]},"DOI":"10.1023\/a:1008409601731","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T14:30:06Z","timestamp":1040567406000},"page":"1351-1353","source":"Crossref","is-referenced-by-count":97,"title":["Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients"],"prefix":"10.1016","volume":"9","author":[{"given":"P.L.","family":"Zinzani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Magagnoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bendandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Fraternali","family":"Orcioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gherlinzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Albertini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.A.","family":"Pileri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008409601731_bb0010","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European\u2013American Classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1023\/A:1008409601731_bb0015","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1200\/JCO.1986.4.7.1094","article-title":"Combined modality treatment of cutaneous T cell lymphoma: Results of a six-year follow-up","volume":"4","author":"Winkler","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008409601731_bb0020","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1023\/A:1008200307625","article-title":"Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. Classification","volume":"8","author":"Ascam","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008409601731_bb0025","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1200\/JCO.1997.15.6.2296","article-title":"Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma","volume":"15","author":"Ansell","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008409601731_bb0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00877241","article-title":"Difluorodeoxycytidine (dFdC, gemcitabine): A phase I study","volume":"10","author":"Polplin","year":"1992","journal-title":"Invest New Drugs"},{"key":"10.1023\/A:1008409601731_bb0035","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1200\/JCO.1991.9.3.491","article-title":"A phase I clinical, plasma and cellular pharmacology study of gemcitabine","volume":"9","author":"Abbruzzese","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008409601731_bb0040","series-title":"(UICC). TNM Classification of Malignant Tumours","author":"International Union against Cancer","year":"1987"},{"key":"10.1023\/A:1008409601731_bb0045","first-page":"1860","article-title":"Report of committee on Hodgkin\u2019s disease staging classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer"},{"issue":"Suppl 1","key":"10.1023\/A:1008409601731_bb0050","first-page":"71","article-title":"Phase II study with gemcitabine in pretreated patients with Hodgkin\u2019s (HD) and non-Hodgkin\u2019s lymphomas (NHL): Results of a multicenter study","volume":"89","author":"Santoro","year":"1997","journal-title":"Blood"},{"key":"10.1023\/A:1008409601731_bb0055","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/jnci\/82.16.1353","article-title":"Activity of fludarabine monophosphate in patients with advanced mycosis fungoides: A Southwest Oncology Group Study","volume":"82","author":"Von Hoff","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1008409601731_bb0060","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00685844","article-title":"Fludarabine- and gemcitabine-induced apoptosis: Incorporation of analogs into DNA is a critical event","volume":"36","author":"Huang","year":"1995","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1023\/A:1008409601731_bb0065","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1182\/blood.V90.1.270","article-title":"Differential incorporation of ara-C, gemcitabine, and fludarabine into replicating and repairing DNA in proliferating human leukemia cells","volume":"90","author":"Iwasaki","year":"1997","journal-title":"Blood"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419616662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419616662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/9\/12\/1351\/19481627\/9-12-1351.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T01:27:01Z","timestamp":1582248421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419616662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12]]},"references-count":12,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1998,12]]}},"alternative-id":["S0923753419616662"],"URL":"https:\/\/doi.org\/10.1023\/a:1008409601731","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1998,12]]}}}